Armenia vs Japan: Tuberculosis patients who tested positive for HIV
Armenia
36 patients
in 2021
Japan
30 patients
in 2021
Armenia rank
100th
Japan rank
102nd
Tuberculosis patients who tested positive for HIV over time
- Armenia
- Japan
How they compare
Armenia currently reports 36 patients against 30 patients in Japan, a difference of 6 patients.
That makes Armenia's figure about 1.2 times Japan's.
The two have swapped places 1 time across 15 shared years of data; in 2007 it was Japan ahead.
Armenia ranks 100th and Japan ranks 102nd of 201 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Japan in 1.
Head to head by decade
| Decade | Armenia | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.33 patients | 58.67 patients | 46.33 patients | Japan |
| 2010s | 65.2 patients | 47.6 patients | 17.6 patients | Armenia |
| 2020s | 37.5 patients | 30.5 patients | 7 patients | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients who tested positive for hiv, Armenia or Japan?
- Armenia, at 36 patients against 30 patients in Japan as of 2021.
- What is the difference in tuberculosis patients who tested positive for hiv between Armenia and Japan?
- 6 patients, with Armenia ahead.
- How many years of comparable data are there for Armenia and Japan?
- 15 years are reported by both, from 2007 to 2021.
- How do Armenia and Japan rank globally for tuberculosis patients who tested positive for hiv?
- Armenia ranks 100th and Japan ranks 102nd of 201 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients who tested positive for HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of tuberculosis (new and relapsed) patients that tested positive for HIV.